Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)

BACKGROUND: Peripheral arterial disease (PAD) has a population prevalence of 4.6% with intermittent claudication (IC) presenting as one of the earliest and most common symptoms. PAD has detrimental effects on patients’ walking ability in terms of maximum walking distance (MWD) and pain-free walking...

Descripción completa

Detalles Bibliográficos
Autores principales: Cayton, Thomas, Harwood, Amy E., Smith, George E., Totty, Joshua P., Carradice, Daniel, Chetter, Ian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340013/
https://www.ncbi.nlm.nih.gov/pubmed/28264725
http://dx.doi.org/10.1186/s13063-017-1844-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340013/
https://www.ncbi.nlm.nih.gov/pubmed/28264725
http://dx.doi.org/10.1186/s13063-017-1844-4

Ejemplares similares